Posilive Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Bangalore, Karnataka, India, established in 2014.
2014 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Posilive Pharmaceuticals Llp

Posilive Pharmaceuticals Llp, a active limited liability partnership, was established on 21 October 2014 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAC-8330. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹5.75 M.

Its leadership includes Raghavendra Jayakumar Yencharla (Designated Partner), Hedna Vishnumurthy Santhrupth (Designated Partner). Past directors included Manojkumar Vaijanathrao Bhutte. Its latest date of accounts and solvency statement 31 March 2025. It is based at No.227, 3Rd Cross, 6Th Stage 3Rd Block, Chikkegowanapalya, Thalaghatt, Apura, Bangalore, Karnataka, 560062.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAC-8330

  • Incorporation Date

    21 October 2014

  • Total Obligation of Contribution

    ₹5.75 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 5.75 M
  • Company Age 11 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 61.47%
  • Profit Growth **** 100.58%
  • Ebitda **** 21.37%
  • Total Assets **** 54.94%
Company report

Posilive Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Posilive Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Posilive Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Raghavendra Jayakumar Yencharla Designated Partner 21 Oct 2014 Current
Hedna Vishnumurthy Santhrupth Designated Partner 21 Oct 2014 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Posilive Pharmaceuticals Llp.

Posilive Pharmaceuticals Llp, for the financial year ended 2022, experienced significant growth in revenue, with a 61.47% increase. The company also saw a substantial improvement in profitability, with a 100.58% increase in profit. The company's net worth witnessed no change by increase of 0%.

Posilive Pharmaceuticals Llp revenue growth over time
Posilive Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 61.47%
*******
*******
*******
*******
Revenue from Operations
*******
 63.24%
*******
*******
*******
*******
Total Assets
*******
 54.94%
*******
*******
*******
*******
Profit or Loss
*******
 100.58%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 21.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Posilive Pharmaceuticals Llp?

Unlock access to Posilive Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Posilive Pharmaceuticals Llp?

Unlock and access historical data on people associated with Posilive Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Posilive Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Posilive Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Posilive Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Posilive Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Posilive Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    The activity Raghavendra Jayakumar Yencharla was appointed as a Designated Partner was appointed as a Designated Partner on 21 Oct 2014 & has been associated with this company since 11 years 4 months . was completed.

  • Director Appointment

    Progress on Hedna Vishnumurthy Santhrupth was appointed as a Designated Partner was appointed as a Designated Partner on 21 Oct 2014 & has been associated with this company since 11 years 4 months . was documented.

  • LLP Incorporation

    Progress on Posilive Pharmaceuticals Llp was registered on 21 Oct 2014 with Roc Bangalore & aged 11 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Posilive Pharmaceuticals Llp?

The LLPIN of Posilive Pharmaceuticals Llp is AAC-8330.

Where is Posilive Pharmaceuticals Llp headquartered?

Posilive Pharmaceuticals Llp is headquartered at No.227, 3Rd Cross, 6Th Stage 3Rd Block, Chikkegowanapalya, Thalaghatt, Apura, Bangalore, Karnataka, 560062.

When was Posilive Pharmaceuticals Llp incorporated?

Posilive Pharmaceuticals Llp was incorporated on 21 October 2014.

Who are the current directors of Posilive Pharmaceuticals Llp?

The current directors of Posilive Pharmaceuticals Llp are

What is the primary industry of Posilive Pharmaceuticals Llp?

The primary industry of Posilive Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available